Federal Official Gazette
THE SECRETARY OF SCIENCE, TECHNOLOGY AND INNOVATION IN HEALTH OF THE MINISTRY OF HEALTH hereby announces, pursuant to item III of Art. 19-R of Law No. 8,080 of September 19, 1990, and the caput of Art. 19 of Decree No. 7,646 of December 21, 2011, a consultation for input from civil society on the recommendation of the Committee on Clinical Protocols and Therapeutic Guidelines of the National Commission for the Incorporation of Technologies into the Unified Health System (Sistema Único de Saúde) – Conitec regarding the proposed update of the Clinical Protocol and Therapeutic Guidelines for Breast Cancer, submitted by the Secretariat of Science, Technology and Innovation in Health – SCTIE/MS, in case file NUP 25000.189265/2025-35.
THE SECRETARY OF SCIENCE, TECHNOLOGY AND INNOVATION IN HEALTH OF THE MINISTRY OF HEALTH hereby announces, pursuant to item III of Art. 19-R of Law No. 8,080 of September 19, 1990, and the caput of Art. 19 of Decree No. 7,646 of December 21, 2011, a consultation for input from civil society on the recommendation of the Committee on Clinical Protocols and Therapeutic Guidelines of the National Commission for the Incorporation of Technologies into the Unified Health System (Sistema Único de Saúde) – Conitec regarding the proposed update of the Clinical Protocol and Therapeutic Guidelines for Differentiated Thyroid Carcinoma, submitted by the Secretariat of Science, Technology and Innovation in Health – SCTIE/MS, in case file NUP 25000.120708/2022-21.
ANS news
No updates.
Open public consultations
- CP 175. Subject: criticisms and suggestions regarding the preliminary recommendations against incorporating the technologies covered by UAT No. 199 – Cholangioscopy, UAT No. 200 – Next-generation sequencing (NGS) panel and UAT No. 206 – Tepotinib hydrochloride. Deadline: Aug 12, 2026 to Aug 31, 2026
Scheduled public hearings
- AP 68. Subject: preliminary recommendation against incorporating the technologies covered by UAT No. 199 – Cholangioscopy, UAT No. 200 – Next-generation sequencing (NGS) panel and UAT No. 206 – Tepotinib hydrochloride. Date: August 20, 2026, from 9:00 a.m. to 1:00 p.m., virtually, via the Microsoft Teams platform.
Open public calls for input
There is no open public call for input.
Open public calls
There are no open public calls
Other news
ANS excludes therapies using special suits from mandatory ASD coverage
Source: noticias.uol.com.br · read the full article
Health sector overhauls management and sustains expansion
Source: valor.globo.com · read the full article
Public hearing discusses solutions to balance the relationship between health plans and private-network professionals
Experts addressed guidelines for drafting a bill aimed at regulating contracts between health plans and physicians, clinics and hospitals
Sources: Federal Official Gazette (DOU) and the ANS website. Press items link to the original article. This brief is for information only and does not constitute legal advice.